EWTX
Edgewise Therapeutics, Inc.Company with tickers: EWTX
CIK
1710072
CUSIP
28036F105
Shares Outstanding
107,593,006
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-05 | Donovan Joanne M. | CMO | Convert | 50,000 |
| 2026-05-05 | Donovan Joanne M. | CMO | Sell | 50,000 |
| 2026-05-05 | Donovan Joanne M. | CMO | Convert | 50,000 |
| 2026-05-04 | Donovan Joanne M. | CMO | Sell | 5,230 |
| 2026-04-01 | Fox Jonathan C | Director | Award | 339 |
| 2026-04-01 | Donovan Joanne M. | CMO | Convert | 28,662 |
| 2026-04-01 | Donovan Joanne M. | CMO | Sell | 28,662 |
| 2026-04-01 | Donovan Joanne M. | CMO | Convert | 28,662 |
| 2026-03-31 | Donovan Joanne M. | CMO | Convert | 21,338 |
| 2026-03-31 | Donovan Joanne M. | CMO | Convert | 21,338 |
| 2026-03-31 | Donovan Joanne M. | CMO | Sell | 21,338 |
| 2026-03-27 | Donovan Joanne M. | CMO | Sell | 9,623 |
| 2026-03-27 | Donovan Joanne M. | CMO | Sell | 6,735 |
| 2026-01-21 | Edris Badreddin | Director | Sell | 7,605 |
| 2026-01-21 | Edris Badreddin | Director | Convert | 7,605 |
| 2026-01-21 | Edris Badreddin | Director | Convert | 66,477 |
| 2026-01-21 | Edris Badreddin | Director | Convert | 7,605 |
| 2026-01-21 | Edris Badreddin | Director | Convert | 10,463 |
| 2026-01-21 | Edris Badreddin | Director | Sell | 13,690 |
| 2026-01-21 | Edris Badreddin | Director | Convert | 10,463 |
| 2026-01-21 | Edris Badreddin | Director | Convert | 13,690 |
| 2026-01-21 | Edris Badreddin | Director | Convert | 66,477 |
| 2026-01-21 | Edris Badreddin | Director | Convert | 13,690 |
| 2026-01-21 | Edris Badreddin | Director | Convert | 17,236 |
| 2026-01-21 | Edris Badreddin | Director | Sell | 10,463 |
| 2026-01-21 | Edris Badreddin | Director | Sell | 17,236 |
| 2026-01-21 | Edris Badreddin | Director | Convert | 17,236 |
| 2026-01-21 | Edris Badreddin | Director | Sell | 66,477 |
| 2026-01-02 | Fox Jonathan C | Director | Award | 473 |
| 2025-11-19 | Martin Christopher Nathan | Director | Other | 0 |
| 2025-11-19 | Martin Christopher Nathan | Director | Award | 45,150 |
| 2025-11-12 | Russell Alan J | Director, Chief Scientific Officer | Convert | 100,000 |
| 2025-11-12 | Russell Alan J | Director, Chief Scientific Officer | Convert | 100,000 |
| 2025-11-12 | Russell Alan J | Director, Chief Scientific Officer | Sell | 100,000 |
| 2025-11-11 | Fox Jonathan C | Director | Buy | 10,700 |
| 2025-11-10 | Nofi Michael | Chief Financial Officer | Other | 0 |
| 2025-11-10 | Nofi Michael | Chief Financial Officer | Award | 262,500 |
| 2025-11-10 | Nofi Michael | Chief Financial Officer | Award | 43,750 |
| 2025-10-01 | Fox Jonathan C | Director | Award | 728 |
| 2025-08-26 | Russell Alan J | Director, Chief Scientific Officer | Convert | 100,000 |
| 2025-08-26 | Russell Alan J | Director, Chief Scientific Officer | Sell | 100,000 |
| 2025-08-26 | Russell Alan J | Director, Chief Scientific Officer | Convert | 100,000 |
| 2025-08-12 | KOCH KEVIN | Director, President and CEO | Sell | 7,972 |
| 2025-08-12 | KOCH KEVIN | Director, President and CEO | Other | 26,410 |
| 2025-08-12 | KOCH KEVIN | Director, President and CEO | Convert | 17,968 |
| 2025-08-12 | KOCH KEVIN | Director, President and CEO | Other | 26,410 |
| 2025-08-12 | KOCH KEVIN | Director, President and CEO | Other | 259,554 |
| 2025-08-12 | KOCH KEVIN | Director, President and CEO | Award | 87,500 |
| 2025-08-12 | KOCH KEVIN | Director, President and CEO | Award | 525,000 |
| 2025-08-12 | KOCH KEVIN | Director, President and CEO | Convert | 17,968 |
| 2025-08-12 | KOCH KEVIN | Director, President and CEO | Other | 26,410 |
| 2025-08-12 | Donovan Joanne M. | CMO | Convert | 5,781 |
| 2025-08-12 | Donovan Joanne M. | CMO | Sell | 2,862 |
| 2025-08-12 | Donovan Joanne M. | CMO | Award | 28,125 |
| 2025-08-12 | Donovan Joanne M. | CMO | Convert | 5,781 |
| 2025-08-12 | Donovan Joanne M. | CMO | Award | 168,750 |
| 2025-08-12 | Blaustein Robert | Chief Development Officer | Award | 105,000 |
| 2025-08-12 | Blaustein Robert | Chief Development Officer | Award | 17,500 |
| 2025-08-12 | Russell Alan J | Director, Chief Scientific Officer | Convert | 5,781 |
| 2025-08-12 | Russell Alan J | Director, Chief Scientific Officer | Sell | 1,907 |
| 2025-08-12 | Russell Alan J | Director, Chief Scientific Officer | Award | 168,750 |
| 2025-08-12 | Russell Alan J | Director, Chief Scientific Officer | Award | 28,125 |
| 2025-08-12 | Russell Alan J | Director, Chief Scientific Officer | Convert | 5,781 |
| 2025-08-12 | MOORE JOHN R | General Counsel | Convert | 5,781 |
| 2025-08-12 | MOORE JOHN R | General Counsel | Award | 26,875 |
| 2025-08-12 | MOORE JOHN R | General Counsel | Sell | 2,098 |
| 2025-08-12 | MOORE JOHN R | General Counsel | Award | 161,250 |
| 2025-08-12 | MOORE JOHN R | General Counsel | Convert | 5,781 |
| 2025-08-12 | Derakhshan Behrad | Chief Business Officer | Award | 180,000 |
| 2025-08-12 | Derakhshan Behrad | Chief Business Officer | Award | 30,000 |
| 2025-08-12 | Derakhshan Behrad | Chief Business Officer | Sell | 2,491 |
| 2025-08-12 | Derakhshan Behrad | Chief Business Officer | Convert | 5,781 |
| 2025-08-12 | Derakhshan Behrad | Chief Business Officer | Convert | 5,781 |
| 2025-08-12 | Carruthers R Michael | Director | Award | 161,250 |
| 2025-08-12 | Carruthers R Michael | Director | Award | 26,875 |
| 2025-08-12 | Carruthers R Michael | Director | Convert | 5,781 |
| 2025-08-12 | Carruthers R Michael | Director | Convert | 5,781 |
| 2025-08-12 | Carruthers R Michael | Director | Sell | 1,428 |
| 2025-07-01 | Fox Jonathan C | Director | Award | 858 |
| 2025-06-16 | Brege Laura | Director | Award | 30,000 |
| 2025-06-16 | Edris Badreddin | Director | Award | 30,000 |
| 2025-06-16 | Fox Jonathan C | Director | Award | 30,000 |
| 2025-06-16 | Morris Arlene | Director | Award | 30,000 |
| 2025-06-16 | ROOT JONATHAN D | Director | Award | 30,000 |
| 2025-06-16 | Thompson Peter A. | Director | Award | 30,000 |
| 2025-05-02 | Russell Alan J | Director, Chief Scientific Officer | Sell | 1,551 |
| 2025-05-02 | Donovan Joanne M. | CMO | Sell | 5,187 |
| 2025-05-02 | Carruthers R Michael | Director | Sell | 1,314 |
| 2025-05-02 | MOORE JOHN R | General Counsel | Sell | 1,930 |
| 2025-05-02 | KOCH KEVIN | Director, President and CEO | Sell | 4,276 |
| 2025-05-02 | Derakhshan Behrad | Chief Business Officer | Sell | 1,691 |
| 2025-05-01 | Russell Alan J | Director, Chief Scientific Officer | Convert | 5,209 |
| 2025-05-01 | Russell Alan J | Director, Chief Scientific Officer | Convert | 5,209 |
| 2025-05-01 | Donovan Joanne M. | CMO | Convert | 10,417 |
| 2025-05-01 | Donovan Joanne M. | CMO | Convert | 10,417 |
| 2025-05-01 | MOORE JOHN R | General Counsel | Convert | 5,209 |
| 2025-05-01 | MOORE JOHN R | General Counsel | Convert | 5,209 |
| 2025-05-01 | KOCH KEVIN | Director, President and CEO | Other | 26,410 |
| 2025-05-01 | KOCH KEVIN | Director, President and CEO | Convert | 10,417 |
| 2025-05-01 | KOCH KEVIN | Director, President and CEO | Other | 26,410 |